Topics

External Collaboration At US FDA Is More Difficult Than At NIH, Sharpless Says

17:32 EDT 2 May 2019 | SCRIP

Acting US FDA commissioner Norman Sharpless outlines some key differences between his new position and his former role at the...

      

Related Stories

 

Original Article: External Collaboration At US FDA Is More Difficult Than At NIH, Sharpless Says

NEXT ARTICLE

More From BioPortfolio on "External Collaboration At US FDA Is More Difficult Than At NIH, Sharpless Says"

Quick Search